Related Experiment Video
Updated: Sep 22, 2025

Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis
Published on: December 8, 2023
Peer support in patients with hematologic malignancies: a systematic review
Hermioni L Amonoo1,2,3, Lauren E Harnedy4, Sophie C Staton4
1Department of Psychosocial Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. hermioni_amonoo@dfci.harvard.edu.
Peer support shows promise for improving physical symptoms in patients with blood cancers and after stem cell transplants. More research is needed to confirm these benefits for these patient groups.
Area of Science:
- Oncology
- Hematology
- Transplantation Medicine
Background:
- Peer support is linked to positive outcomes in solid tumor patients.
- Limited research exists on peer support for hematologic malignancies and hematopoietic stem cell transplantation (HSCT).
Purpose of the Study:
- To systematically review the literature on peer support and clinical outcomes in hematologic malignancy patients and HSCT recipients.
- To identify the current state of research and potential benefits of peer support in these populations.
Main Methods:
- Systematic review conducted following PRISMA guidelines.
- Searched five databases for relevant studies.
- Included studies examining peer support and clinical outcomes.
Main Results:
- Eight studies involving 574 patients were included.
- Four intervention studies suggested peer support may improve physical symptoms.
- Two studies indicated a need for more evidence-based peer support interventions for HSCT patients.
Conclusions:
- A significant gap exists in the literature regarding peer support for hematologic malignancy patients and HSCT recipients.
- Preliminary findings suggest a positive association between peer support and better health outcomes.
- Further randomized controlled trials are necessary to establish the role and efficacy of peer support interventions in these populations.
More Related Videos
06:39Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
Published on: October 3, 2018
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
Related Concept Videos
Regulation of Hematopoietic Stem Cells
Treatment Resistant Cancers
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Hematopoiesis
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...